Wednesday, December 10, 2014

BWI: Kezzler Adopted By UCB For Consumer Protection Of Pharmaceutical Products In India

 
Source : Kezzler
Wednesday, December 10, 2014 3:18PM IST (9:48AM GMT)
 
Kezzler Adopted By UCB For Consumer Protection Of Pharmaceutical Products In India
 
Mumbai, Maharashtra, India

Kezzler AS, a global leader in brand protection at the unit level, has been adopted by Belgian pharmaceuticals giant UCB for the Indian market. UCB have for several years applied Kezzler’s technology platform for protection of its exported products out of India. The new partnership expands that operation to cover domestic products within the Indian market, with expected rollout in 2015 Q1.

Kezzler was the first company to introduce the concept of serialization to India as a way to protect both consumers and brand owners against the menace of counterfeiting, duplication, product diversion, and other illegal activities. UCB was among the first companies to use the Kezzler technology, which allows consumers to instantly verify after purchase whether the medicine is genuine, within the valid expiry period, and not subject to a recall notice. A simple SMS of a unique code on the package (or scanning of the barcode with a Smartphone) covers all of the possible safety provisions.

Mr. Milind Kulkarni, Director of Supply Chain at UCB said, "When it comes to patient protection, it is most important to select the right technology. Kezzler has a proven track record of success, both in India and across the world. Our own experience with Kezzler has been absolutely superb and they were the natural choice as we plan to expand our consumer protection program for the Indian domestic market in 2015".

Dr. Avi Chaudhuri, Chief Business Officer and head of Kezzler's India operations, added "UCB has been a leader in taking proactive steps to protect their consumers. We have been proud to be associated with UCB in India and now look forward to a much larger program as we expand our operational activities."

Kezzler’s approach to serialization and track and trace starts with a Unique Identifier Code (UID) for secure generation and authentication/tracing of codes (encrypted digital identities) in a mass production environment and at the unit level in multiple business sectors, including pharmaceuticals, consumer goods, food and dairy to mention a few.

“We believe our technology platform has been proven as a cost effective business solution in preventing counterfeit products with seven of the top 10 pharmaceutical companies in the world and is now being utilized with global consumer goods companies,” said Kezzler CEO Mr. Magnar Loken. “The scalability and power of our platform is something that has been proven in the brand protection space and now is gaining significant traction in supply chain management and consumer engagement via mobile and digital applications.”

To learn more about Kezzler, visit www.kezzler.com

About Kezzler

Founded in 2001, Kezzler AS is a global leader in serializing products at the unit level. Having a strong patent position (EU and USPTO) on encryption technology and track and trace, Kezzler is the only company in the world with a mature serialization technology platform and record of execution in multiple service verticals that include Track & Trace, brand protection, and direct-to-consumer mobile marketing. Headquartered in Oslo, Norway, the company has offices in India, United States, Spain, Hong Kong, Austria, Kenya and China.

 
Media Contact Details

Mr. Paul Laland, Kezzler, ,+1.415.519.6610 , p.laland@kezzler.com

 

KEYWORDS: Business/ Finance:Advertising, PR & marketing, Business Services, Healthcare & biotechnology, Pharmaceutical

 

To ensure that you continue to receive email from Business Wire India in your inbox, please add businesswireindia.com to your Address Book or Safe List.

 
To submit a press release, click here.
To unsubscribe or modify your Business Wire India settings, please visit your profile page on Business Wire India.

Connect with us on: Facebook | Twitter | Google+
 
Note : This is system generated mail. Please do not reply to it.
 

No comments:

Post a Comment